DE3882154T2 - Verfahren zur Herstellung des pres 1/S2/S-Hepatitis-B-Antigens aus Hefe. - Google Patents

Verfahren zur Herstellung des pres 1/S2/S-Hepatitis-B-Antigens aus Hefe.

Info

Publication number
DE3882154T2
DE3882154T2 DE88301382T DE3882154T DE3882154T2 DE 3882154 T2 DE3882154 T2 DE 3882154T2 DE 88301382 T DE88301382 T DE 88301382T DE 3882154 T DE3882154 T DE 3882154T DE 3882154 T2 DE3882154 T2 DE 3882154T2
Authority
DE
Germany
Prior art keywords
antigen
yeast
hepatitis
pres
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE88301382T
Other languages
English (en)
Other versions
DE3882154D1 (de
Inventor
Shigeko Yamazaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE3882154D1 publication Critical patent/DE3882154D1/de
Publication of DE3882154T2 publication Critical patent/DE3882154T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
DE88301382T 1987-02-27 1988-02-18 Verfahren zur Herstellung des pres 1/S2/S-Hepatitis-B-Antigens aus Hefe. Expired - Fee Related DE3882154T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1982087A 1987-02-27 1987-02-27

Publications (2)

Publication Number Publication Date
DE3882154D1 DE3882154D1 (de) 1993-08-12
DE3882154T2 true DE3882154T2 (de) 1993-12-02

Family

ID=21795203

Family Applications (1)

Application Number Title Priority Date Filing Date
DE88301382T Expired - Fee Related DE3882154T2 (de) 1987-02-27 1988-02-18 Verfahren zur Herstellung des pres 1/S2/S-Hepatitis-B-Antigens aus Hefe.

Country Status (5)

Country Link
EP (1) EP0280470B1 (de)
JP (1) JPS63270628A (de)
AT (1) ATE91304T1 (de)
DE (1) DE3882154T2 (de)
DK (1) DK100888A (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3883596T2 (de) * 1987-03-09 1994-02-17 Merck & Co Inc Reinigung von rekombiniertem Hepatitis-B-Oberflächen-Antigen.
US5011915A (en) * 1987-10-26 1991-04-30 Merck & Co., Inc. Process for purifying recombinant hepatitis antigens
EP0314240A3 (de) * 1987-10-26 1990-03-28 Merck & Co. Inc. Verfahren für de Reinigung von rekombinanten Hepatitis-Antigenen
EP0328123A1 (de) * 1988-02-09 1989-08-16 Eugene Tech International, Inc. Pre-S-reiches Hepatitis-B-Oberflächenantigen
IL99025A0 (en) * 1990-08-15 1992-07-15 Astra Ab Novel process for the detection of pathogens using dna probes
CU22290A1 (es) * 1990-10-08 1995-01-31 Cigb Procedimiento para la obtencion de antigeno de superficie del virus de la hepatitis b de superior capacidad inmunoganica y su uso en un preparado vacunal
US5102989A (en) * 1991-03-15 1992-04-07 Merck & Co., Inc. Method of stabilizing recombinant hepatitis B virus surface proteins from recombinant host cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR76274B (de) * 1981-08-04 1984-08-04 Univ California
KR850001534A (ko) * 1983-08-22 1985-03-30 제임스 에프. 나우톤 형질전환된 효모로 부터 유도된 면역원성 HBsAg
US4649192A (en) * 1985-05-30 1987-03-10 Smith Kline-Rit Method for the isolation and purification of hepatitis B surface antigen using polysorbate
EP0232410A4 (de) * 1985-08-15 1988-01-25 Amgen Spaltverfahren und puffer zur extraktion von hepatitis-b-oberflächenantigen aus hefezellen.
US4895800A (en) * 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen

Also Published As

Publication number Publication date
EP0280470B1 (de) 1993-07-07
ATE91304T1 (de) 1993-07-15
JPS63270628A (ja) 1988-11-08
EP0280470A1 (de) 1988-08-31
DK100888D0 (da) 1988-02-26
DE3882154D1 (de) 1993-08-12
DK100888A (da) 1988-10-28

Similar Documents

Publication Publication Date Title
DE68929115T2 (de) Verfahren zur Herstellung von menschlichem Serumalbumin in Hefe
FI101381B1 (fi) Nukleotidisekvenssi ja menetelmä polypeptidin HSA(1-387) tuottamiseksi
ATE170630T1 (de) Proteine mit geänderten epitopen und verfahren zur deren herstellung
DE69110663D1 (de) Verfahren zur herstellung eines enzymhydrolysates.
ATE68826T1 (de) Verfahren zur herstellung von reifem, menschlichem serum-albumin.
ATE123780T1 (de) Verfahren zur verwendung und herstellung von peptiden.
DE69031791T2 (de) Verfahren zur HCV-Züchtung in Zell-Linien aus B- oder T-Lymphozyten
DE69210645T2 (de) Verfahren zur Herstellung von cysteinfreien Peptiden
ATE132904T1 (de) Verfahren zur herstellung von trehalulose und isomaltulose
ATE138923T1 (de) Verfahren zur herstellung gereinigter glycolipide durch membrantrennverfahren
ATE166881T1 (de) Verfahren zur herstellung von faktor viii
ATE30844T1 (de) Verfahren zur herstellung der wichtigsten proteine des haemolysierten bluts in einer nichtdenaturierten form.
DE3882154T2 (de) Verfahren zur Herstellung des pres 1/S2/S-Hepatitis-B-Antigens aus Hefe.
ATE131490T1 (de) Verfahren zur herstellung von gereinigten albuminlösungen
ES2080047T3 (es) Peptidos hiv y metodos para la deteccion de hiv.
ATE48014T1 (de) Vorrichtung zur abtrennung von produkten aus einem produkt-substrat-gemisch.
AT384032B (de) Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag)
ATE82471T1 (de) Verfahren zur abtrennung bestimmter proteine aus molke.
ES2041690T3 (es) Metodo para la purificacion de anticuerpos.
ATE37873T1 (de) Verfahren zur herstellung optisch aktiver 1,4dihydropyridine.
ATE99323T1 (de) Verfahren zur wiedergewinnung eines gereinigten epi-proteins aus einer loesung, insbesondere einer gaerungsloesung.
DK628188D0 (da) Protein og fremgangsmaade til fremstilling deraf
ATE91303T1 (de) Verfahren zur herstellung von peptiden durch spezifische spaltung von gentechnisch gewonnenen fusionsproteinen mit collagenasen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee